1. Hamed E A, El-Noweihi A M, Mohamed A Z et al. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions. Respirology, 2004,9(1):81–86
2. Li Y H, Xie C M. Advanced study in pathogenesis of tuberculous pleuritis. Guowei Yixue Neikexue Fence (Chinese), 2002,29(9):373–376
3. Verheul H M, Hoekman K, Jorna A S et al. Targeting vascular endothelial growth factor blockade: ascites and pleural effusions formation. Oncologist, 2000,5(Suppl 1):45–50
4. Yano S, Herbst R S, Shinohara H et al. Treatment for malignant pleural effusions of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res, 2000,6(3):957–965
5. Hiraki A, Aoe K, Matsuo K et al. Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion. Int J Tuberc Lung Dis, 2003,7(12):1172–1177